- Icafolin-methyl is the first new mode of action for weed control in over 30 years.
- Bayer expects Icafolin to launch in Brazil from 2028, with peak sales potential of €750 million.
- Icafolin's unique properties allow for lower dose rates and targeted applications.
- Icafolin is the first product using Bayer's CropKey R&D approach.
Introduction
Bayer has submitted registration applications for its novel herbicide, icafolin-methyl, in the European Union, following earlier submissions in Brazil, the United States, and Canada. This marks a significant regulatory milestone for the company.
Icafolin-Methyl
Icafolin-methyl introduces the first new mode of action for post-emergent weed control in broadacre crops in over 30 years. It belongs to a new chemical class that offers unique properties, such as lower dose rates and more targeted applications, while maintaining a strong safety and sustainability profile.
Market Potential
Bayer anticipates launching icafolin-methyl in Brazil from 2028, with an estimated peak sales potential of €750 million. The company's new operating model, DSO, has been instrumental in advancing regulatory submissions ahead of schedule.
Weed Resistance
Icafolin-methyl complements existing herbicides like glyphosate, providing a novel solution to combat weed resistance, a growing global issue threatening food security. The herbicide's unique properties help reduce the need for tillage, supporting regenerative agricultural practices that improve soil health.
CropKey R&D Approach
Icafolin-methyl is the first product developed using Bayer's CropKey R&D approach, which optimizes formulation by considering efficacy, safety, sustainability, and farmer convenience. This approach accelerates the development of future products targeting specific proteins in weeds, pests, and crop diseases.
Future Plans
Following its initial launch in Brazil, Bayer plans to expand icafolin-methyl's availability to the U.S., Canada, EU, and other regions in subsequent years.
